West Pharmaceutical Services Common Stock Net 2010-2024 | WST

West Pharmaceutical Services common stock net from 2010 to 2024. Common stock net can be defined as the value of common equity ownership.
  • West Pharmaceutical Services common stock net for the quarter ending June 30, 2024 was $0.019B, a 0% increase year-over-year.
  • West Pharmaceutical Services common stock net for 2023 was $0.019B, a 0% decline from 2022.
  • West Pharmaceutical Services common stock net for 2022 was $0.019B, a 0% decline from 2021.
  • West Pharmaceutical Services common stock net for 2021 was $0.019B, a 0% decline from 2020.
West Pharmaceutical Services Annual Common Stock Net
(Millions of US $)
2023 $19
2022 $19
2021 $19
2020 $19
2019 $19
2018 $19
2017 $19
2016 $18
2015 $18
2014 $18
2013 $18
2012 $17
2011 $9
2010 $9
2009 $9
West Pharmaceutical Services Quarterly Common Stock Net
(Millions of US $)
2024-06-30 $19
2024-03-31 $19
2023-12-31 $19
2023-09-30 $19
2023-06-30 $19
2023-03-31 $19
2022-12-31 $19
2022-09-30 $19
2022-06-30 $19
2022-03-31 $19
2021-12-31 $19
2021-09-30 $19
2021-06-30 $19
2021-03-31 $19
2020-12-31 $19
2020-09-30 $19
2020-06-30 $19
2020-03-31 $19
2019-12-31 $19
2019-09-30 $19
2019-06-30 $19
2019-03-31 $19
2018-12-31 $19
2018-09-30 $19
2018-06-30 $19
2018-03-31 $19
2017-12-31 $19
2017-09-30 $19
2017-06-30 $19
2017-03-31 $19
2016-12-31 $18
2016-09-30 $18
2016-06-30 $18
2016-03-31 $18
2015-12-31 $18
2015-09-30 $18
2015-06-30 $18
2015-03-31 $18
2014-12-31 $18
2014-09-30 $18
2014-06-30 $18
2014-03-31 $18
2013-12-31 $18
2013-09-30 $18
2013-06-30 $9
2013-03-31 $9
2012-12-31 $17
2012-09-30 $9
2012-06-30 $9
2012-03-31 $9
2011-12-31 $9
2011-09-30 $9
2011-06-30 $9
2011-03-31 $9
2010-12-31 $9
2010-09-30 $9
2010-06-30 $9
2010-03-31 $9
2009-12-31 $9
2009-09-30 $9
2009-06-30 $9
2009-03-31 $9
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.428B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.939B 18.14
McKesson (MCK) United States $66.345B 18.25
Cardinal Health (CAH) United States $26.957B 14.91
Cooper (COO) United States $22.013B 31.33
Labcorp (LH) United States $19.078B 15.89
Align Technology (ALGN) United States $18.899B 36.51
Henry Schein (HSIC) United States $9.181B 16.81
Merit Medical Systems (MMSI) United States $5.746B 30.37
DENTSPLY SIRONA (XRAY) United States $5.414B 14.52
CONMED (CNMD) United States $2.343B 20.38
Patterson (PDCO) United States $1.936B 10.21
STAAR Surgical (STAA) United States $1.544B 69.76
Lifevantage (LFVN) United States $0.127B 17.48
Pro-Dex (PDEX) United States $0.086B 41.13